Search for: "GlaxoSmithKline, LLC " Results 21 - 40 of 164
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Nov 2020, 9:45 am by Steve Brachmann
GlaxoSmithKline LLC in which the appellate court affirmed a judgment entered against GlaxoSmithKline in the District of Delaware finding that GSK’s Ellipta-brand inhalers infringed patent claims asserted by Vectura. [read post]
22 Jan 2021, 2:00 am by Katharine Van Tassel
Carrier (Rutgers Law School), Matthew J Dowd, Robert Scheffel, Corrected Brief of Amici Curiae Fifty-Seven Law, Economics, Business, Health, and Medicine Professors in Support of Cross-Appellant's Petition for Rehearing En Banc, Federal Circuit brief in GlaxoSmithKline LLC v.... [read post]
23 Apr 2013, 1:00 am by Margareta Sorenson
GlaxoSmithKline LLC, the Federal Circuit upheld a narrow claim interpretation based on prosecution history disclaimer. [read post]
15 Dec 2020, 12:21 pm by Dennis Crouch
Certified Aviation Services, LLC  (automation & eligibility) [EcoWashingMachine][CAFC Decision] GlaxoSmithKline LLC v. [read post]
3 Jul 2012, 6:18 am by Heidi Henson
Global health care giant GlaxoSmithKline LLC (GSK) agreed to plead guilty and to pay $3 billion to resolve its criminal and civil liability arising from the company’s unlawful promotion of certain prescription drugs, its failure to report certain safety data, and its civil liability for alleged false price reporting practices, the Justice Department announced on July 2. [read post]
24 Apr 2011, 8:43 pm by Patent Docs
.; GlaxoSmithKline LLC; Human Genome Sciences, Inc.; Lonza Biologics PLC; Lonza Biologics Inc. [read post]
21 Nov 2010, 6:23 pm by Josh Myers
Myers is the owner and President of Myers Injury Law, LLC and a founding partner of Schultz & Myers, LLC. [read post]
19 Nov 2020, 3:18 pm by Lawrence B. Ebert
GSK lost its appeal at the CAFC: Following trial, a jury in the United States District Court for the District of Delaware found that defendants GlaxoSmithKline LLC and Glaxo Group Limited (collectively, “GSK”) infringed U.S. [read post]
3 Jul 2012, 8:17 am by Brian Wolfman
Yesterday, the Justice Department announced that the Deparment along with its law enforcement partners have reached an historic $3 billion resolution with the pharmaceutical manufacturer GlaxoSmithKline, LLC, to resolve multiple investigations into the company’s sales, marketing, and pricing practices. [read post]
3 Sep 2012, 8:55 pm by Patent Docs
GlaxoSmithKline LLC v. [read post]
2 Jul 2012, 2:57 am by Ben Vernia
On July 2, the Department of Justice announced the largest-ever healthcare fraud settlement, with GlaxoSmithKline. [read post]
29 Apr 2024, 4:15 am by Susan Smigielski-Acker
LLC (collectively Pfizer) and BioNTech SE, BioNTech Manufacturing GMBH and BioNTech US Inc. [read post]
18 Dec 2023, 9:07 pm by Patent Docs
§ 355(j)(2)(A)(viii) (the so-called "skinny label) has in the recent past raised something of a kerfuffle before the Federal Circuit (see "GlaxoSmithKline LLC v. [read post]
29 Apr 2024, 4:15 am by Susan Smigielski-Acker
LLC (collectively Pfizer) and BioNTech SE, BioNTech Manufacturing GMBH and BioNTech US Inc. [read post]
17 Mar 2011, 3:16 pm by Tomassi Law Associates
Tomassi Law Associates, LLC www.attorney-ri.com 1-888-RI-LAWLINEGREENBELT, Md., March 17 (Reuters) – A federal judge is considering whether to dismiss an indictment against a former GlaxoSmithKline PLC (GSK.L) lawyer after new evidence emerged about possible prosecutorial errors in her indictment. [read post]